Viral respiratory tract infection
MONDO:0024352A respiratory tract infection caused by a virus. Viruses represent the most common causes of upper and lower respiratory tract infections and include rhinoviruses, influenza viruses, parainfluenza viruses, and respiratory syncytial virus.
Also known as: viral respiratory tract infection
603 clinical trials for this condition and its sub-types, 47 tagged with Viral respiratory tract infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Viral respiratory tract infection
-
Influenza 334 trials · 345 incl. sub-types
2 sub-types
- Swine influenza 35 trials
- Avian influenza 15 trials
-
Respiratory syncytial virus infectious disease 168 trials · 170 incl. sub-types
1 sub-type
-
Common cold 36 trials
-
Viral pneumonia 27 trials
1 sub-type
- Cytomegalovirus pneumonia 0 trials Sub-types →
-
Hantavirus pulmonary syndrome 2 trials
-
Viral laryngitis 0 trials
Most studied deeper sub-types
-
New Single-Dose flu drug shows promise in kids trial
Disease control CompletedThis study tested a new flu medicine called ZX-7101A in 169 children aged 2 to 11. The medicine was given as a single oral dose, and researchers compared it to a standard 5-day treatment (oseltamivir). The main goal was to check safety and how well it relieved flu symptoms. The t…
Phase 3 • Sponsor: Nanjing Zenshine Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New antiviral pill could shorten your next cold
Disease control CompletedThis study tested whether the antiviral drug Amizon (enisamium iodide) can help adults with colds or flu feel better faster. One hundred adults aged 18 to 60 took either Amizon or a placebo pill for 7 days, starting within a day of their first symptoms. Researchers tracked sympto…
Phase 2/3 • Sponsor: Joint Stock Company "Farmak" • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could a cold virus drug prevent COPD Flare-Ups?
Disease control CompletedThis study tested whether the drug vapendavir can reduce breathing problems in people with COPD who catch a rhinovirus (common cold). Fifty-two adults with COPD were given either vapendavir or a placebo after being exposed to the virus. The main goal was to see if vapendavir lowe…
Phase 2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
UV water treatment tested to keep kids healthy
Prevention CompletedThis study tested whether treating private well water with ultraviolet (UV) light can prevent stomach and respiratory infections in children under 5. Researchers gave 28 Pennsylvania households either a real UV device or a fake one and tracked illness symptoms via weekly texts. T…
Sponsor: Temple University • Aim: Prevention
Last updated Sep 21, 2026 19:00 UTC
-
Could a special light keep nursing home residents safer from flu and COVID?
Prevention CompletedThis study tested whether far-UVC light, a safe type of ultraviolet light, can reduce respiratory infections like flu and COVID-19 in long-term care facilities. The trial involved 550 elderly residents who are at higher risk due to age and health conditions. The light was used as…
Sponsor: Kenneth Rockwood • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Can a common supplement stop severe COVID? early trial tests MitoQ
Prevention CompletedThis study tested whether the dietary supplement MitoQ could prevent severe viral infections, like COVID-19, in adults who had close contact with a sick person. Eighty asymptomatic adults were given MitoQ or no treatment and monitored for illness. The goal was to see if the suppl…
Phase 1/2 • Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Can a virus tip the balance? unraveling lung bacteria in cystic fibrosis
Knowledge-focused CompletedThis study investigates how viral infections influence the community of bacteria in the airways of young children with cystic fibrosis. Researchers will collect throat swabs from children under 5 years old over one year, tracking their microbiome, inflammation, and clinical sympt…
Sponsor: University Hospital, Antwerp • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Pandemic shifts germ landscape: study reveals new patterns in respiratory infections
Knowledge-focused CompletedThis study looked at 537 patients with respiratory infection symptoms to see how the types of viruses and bacteria changed from the COVID-19 pandemic period to after it. Researchers used a special PCR test to detect multiple germs at once. The goal was to understand how pandemic …
Sponsor: Hisar Intercontinental Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Blood marker may guide antiviral treatment duration for respiratory infections
Knowledge-focused CompletedThis study tested whether measuring a protein called MxA in the blood can help doctors decide when to stop antiviral drugs in patients with flu or COVID-19. Researchers enrolled 86 adults and compared standard care to MxA-guided treatment. The goal was to see if the test could re…
Sponsor: Capital Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Vitamin B3 study explores how body handles supplement during illness
Knowledge-focused CompletedThis completed study looked at how a special form of vitamin B3 (nicotinamide) is processed in 28 patients with low tryptophan levels due to respiratory infections or inflammatory bowel disease. Participants took either 500 mg or 1000 mg of the supplement daily for four weeks. Th…
Sponsor: University Hospital Schleswig-Holstein • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:47 UTC